Global Oral Vaccines Market Research Report 2026(Status and Outlook)

February 2026 | 154 pages | ID: G43C863FB0A9EN
Bosson Research

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oral Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Oral vaccines are immunological products administered via the oral route that induce mucosal (and often systemic) immune responses within the gastrointestinal tract. Unlike injectable vaccines, oral vaccines can take the form of live-attenuated strains, engineered microbial carriers, recombinant oral delivery platforms, or oral capsule/tablet formulations that present antigen to gut-associated lymphoid tissue (GALT), eliciting both secretory IgA and systemic antibodies. The inherent advantages of oral delivery include needle-free administration, suitability for mass campaigns and low-resource settings, and improved acceptability among recipients. Contemporary oral vaccine R&D emphasizes gut-microbiome considerations, particulate or nano-delivery systems, and engineered biological carriers to mitigate gastric degradation and immune tolerance?positioning oral vaccines as strategically important tools for infectious disease control and rapid-response immunization programs.In 2024, global Oral vaccines production reached approximately 2069 m dose, with an average global market price of around US$ 1.3 per dose.The average gross profit margin for this product is 62%.Oral vaccines sit at the confluence of public-health policy and vaccine-delivery innovation, benefiting from policy emphasis and investment in needle-free, highly distributable immunization strategies. Their non-invasive and simple administration makes oral formats especially attractive for traveler immunizations, enteric disease prevention, and community-based campaigns. Ongoing clinical progress reported by several industry players and advances in stabilizing technologies, acid-resistant carriers, and oral delivery platforms have converted conceptual advantages into reproducible product designs?opening pathways to scale-up and cross-border deployment.Key risks include variability in vaccine efficacy driven by gastrointestinal factors, heterogeneity of individual immune responses, and divergent regulatory expectations across jurisdictions. Such biological and regulatory complexity increases the burden of evidence required for global approval and public-program inclusion. Moreover, entrenched injectable vaccine procurement, reimbursement frameworks, and supply chains may slow the rate at which oral vaccines displace existing products; developers must therefore invest heavily in demonstrable clinical benefits, scalable manufacturing, and channel development to mitigate these constraints.Primary healthcare providers, international aid programs, and travel medicine markets show growing demand for convenient, safe, and cost-effective vaccines. Community-level immunization prefers needle-free, easily distributable products that simplify mass campaigns and follow-up. In high-income settings, oral vaccines that demonstrate additional mucosal immunity benefits could be positioned as complementary or transmission-blocking options. End-user preferences for needle-free administration and reduced clinical resource needs enhance the appeal of oral formats, while procurement decisions increasingly weigh storage stability and cold-chain dependency.Critical upstream components include biological carrier platforms or recombinant antigen production systems, gastro-protective excipients (acid-resistant coatings and protectants), stabilizers for ambient storage, and scalable biomanufacturing capacity. As the sector moves toward regulated, large-scale supply, manufacturers and suppliers are prioritizing batch consistency, ambient stability, and greener production methods to support deployment in low-resource settings. Safety profiling of biological carriers, regulatory compliance for genetic constructs, and excipient quality standards are central considerations in supply-chain design?ultimately determining the economic viability of moving oral vaccine candidates from trials into population-level use.

The global Oral Vaccines market size was estimated at USD 2690.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Oral Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Oral Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oral Vaccines market.

Global Oral Vaccines Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
CNBG

Market Segmentation (by Type)

Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other

Market Segmentation (by Application)

Public
Private

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oral Vaccines Market
Overview of the regional outlook of the Oral Vaccines Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oral Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Oral Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Oral Vaccines
1.2 Key Market Segments
  1.2.1 Oral Vaccines Segment by Type
  1.2.2 Oral Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ORAL VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Oral Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Oral Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ORAL VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Oral Vaccines Product Life Cycle
3.3 Global Oral Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Oral Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oral Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oral Vaccines Market Competitive Situation and Trends
  3.8.1 Oral Vaccines Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Oral Vaccines Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ORAL VACCINES INDUSTRY CHAIN ANALYSIS

4.1 Oral Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ORAL VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Oral Vaccines Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Oral Vaccines Market
5.7 ESG Ratings of Leading Companies

6 ORAL VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oral Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Oral Vaccines Market Size by Type (2020-2025)
6.4 Global Oral Vaccines Price by Type (2020-2025)

7 ORAL VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oral Vaccines Market Sales by Application (2020-2025)
7.3 Global Oral Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Oral Vaccines Sales Growth Rate by Application (2020-2025)

8 ORAL VACCINES MARKET SALES BY REGION

8.1 Global Oral Vaccines Sales by Region
  8.1.1 Global Oral Vaccines Sales by Region
  8.1.2 Global Oral Vaccines Sales Market Share by Region
8.2 Global Oral Vaccines Market Size by Region
  8.2.1 Global Oral Vaccines Market Size by Region
  8.2.2 Global Oral Vaccines Market Size by Region
8.3 North America
  8.3.1 North America Oral Vaccines Sales by Country
  8.3.2 North America Oral Vaccines Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Oral Vaccines Sales by Country
  8.4.2 Europe Oral Vaccines Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Oral Vaccines Sales by Region
  8.5.2 Asia Pacific Oral Vaccines Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Oral Vaccines Sales by Country
  8.6.2 South America Oral Vaccines Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Oral Vaccines Sales by Region
  8.7.2 Middle East and Africa Oral Vaccines Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ORAL VACCINES MARKET PRODUCTION BY REGION

9.1 Global Production of Oral Vaccines by Region(2020-2025)
9.2 Global Oral Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oral Vaccines Production
  9.4.1 North America Oral Vaccines Production Growth Rate (2020-2025)
  9.4.2 North America Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oral Vaccines Production
  9.5.1 Europe Oral Vaccines Production Growth Rate (2020-2025)
  9.5.2 Europe Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oral Vaccines Production (2020-2025)
  9.6.1 Japan Oral Vaccines Production Growth Rate (2020-2025)
  9.6.2 Japan Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oral Vaccines Production (2020-2025)
  9.7.1 China Oral Vaccines Production Growth Rate (2020-2025)
  9.7.2 China Oral Vaccines Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Merck
  10.1.1 Merck Basic Information
  10.1.2 Merck Oral Vaccines Product Overview
  10.1.3 Merck Oral Vaccines Product Market Performance
  10.1.4 Merck Business Overview
  10.1.5 Merck SWOT Analysis
  10.1.6 Merck Recent Developments
10.2 GSK
  10.2.1 GSK Basic Information
  10.2.2 GSK Oral Vaccines Product Overview
  10.2.3 GSK Oral Vaccines Product Market Performance
  10.2.4 GSK Business Overview
  10.2.5 GSK SWOT Analysis
  10.2.6 GSK Recent Developments
10.3 Sanofi
  10.3.1 Sanofi Basic Information
  10.3.2 Sanofi Oral Vaccines Product Overview
  10.3.3 Sanofi Oral Vaccines Product Market Performance
  10.3.4 Sanofi Business Overview
  10.3.5 Sanofi SWOT Analysis
  10.3.6 Sanofi Recent Developments
10.4 Lanzhou Institute
  10.4.1 Lanzhou Institute Basic Information
  10.4.2 Lanzhou Institute Oral Vaccines Product Overview
  10.4.3 Lanzhou Institute Oral Vaccines Product Market Performance
  10.4.4 Lanzhou Institute Business Overview
  10.4.5 Lanzhou Institute Recent Developments
10.5 Serum Institute
  10.5.1 Serum Institute Basic Information
  10.5.2 Serum Institute Oral Vaccines Product Overview
  10.5.3 Serum Institute Oral Vaccines Product Market Performance
  10.5.4 Serum Institute Business Overview
  10.5.5 Serum Institute Recent Developments
10.6 Valneva
  10.6.1 Valneva Basic Information
  10.6.2 Valneva Oral Vaccines Product Overview
  10.6.3 Valneva Oral Vaccines Product Market Performance
  10.6.4 Valneva Business Overview
  10.6.5 Valneva Recent Developments
10.7 Shanghai United Cell
  10.7.1 Shanghai United Cell Basic Information
  10.7.2 Shanghai United Cell Oral Vaccines Product Overview
  10.7.3 Shanghai United Cell Oral Vaccines Product Market Performance
  10.7.4 Shanghai United Cell Business Overview
  10.7.5 Shanghai United Cell Recent Developments
10.8 Bibcol
  10.8.1 Bibcol Basic Information
  10.8.2 Bibcol Oral Vaccines Product Overview
  10.8.3 Bibcol Oral Vaccines Product Market Performance
  10.8.4 Bibcol Business Overview
  10.8.5 Bibcol Recent Developments
10.9 PaxVax
  10.9.1 PaxVax Basic Information
  10.9.2 PaxVax Oral Vaccines Product Overview
  10.9.3 PaxVax Oral Vaccines Product Market Performance
  10.9.4 PaxVax Business Overview
  10.9.5 PaxVax Recent Developments
10.10 Vabiotech
  10.10.1 Vabiotech Basic Information
  10.10.2 Vabiotech Oral Vaccines Product Overview
  10.10.3 Vabiotech Oral Vaccines Product Market Performance
  10.10.4 Vabiotech Business Overview
  10.10.5 Vabiotech Recent Developments
10.11 Tiantan Biological
  10.11.1 Tiantan Biological Basic Information
  10.11.2 Tiantan Biological Oral Vaccines Product Overview
  10.11.3 Tiantan Biological Oral Vaccines Product Market Performance
  10.11.4 Tiantan Biological Business Overview
  10.11.5 Tiantan Biological Recent Developments
10.12 EuBiologics
  10.12.1 EuBiologics Basic Information
  10.12.2 EuBiologics Oral Vaccines Product Overview
  10.12.3 EuBiologics Oral Vaccines Product Market Performance
  10.12.4 EuBiologics Business Overview
  10.12.5 EuBiologics Recent Developments
10.13 Panacea Biotec Ltd
  10.13.1 Panacea Biotec Ltd Basic Information
  10.13.2 Panacea Biotec Ltd Oral Vaccines Product Overview
  10.13.3 Panacea Biotec Ltd Oral Vaccines Product Market Performance
  10.13.4 Panacea Biotec Ltd Business Overview
  10.13.5 Panacea Biotec Ltd Recent Developments
10.14 Bio-Med
  10.14.1 Bio-Med Basic Information
  10.14.2 Bio-Med Oral Vaccines Product Overview
  10.14.3 Bio-Med Oral Vaccines Product Market Performance
  10.14.4 Bio-Med Business Overview
  10.14.5 Bio-Med Recent Developments
10.15 Halfkin Bio-Pharmaceuticals
  10.15.1 Halfkin Bio-Pharmaceuticals Basic Information
  10.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Overview
  10.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Market Performance
  10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
  10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
10.16 CNBG
  10.16.1 CNBG Basic Information
  10.16.2 CNBG Oral Vaccines Product Overview
  10.16.3 CNBG Oral Vaccines Product Market Performance
  10.16.4 CNBG Business Overview
  10.16.5 CNBG Recent Developments

11 ORAL VACCINES MARKET FORECAST BY REGION

11.1 Global Oral Vaccines Market Size Forecast
11.2 Global Oral Vaccines Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Oral Vaccines Market Size Forecast by Country
  11.2.3 Asia Pacific Oral Vaccines Market Size Forecast by Region
  11.2.4 South America Oral Vaccines Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Oral Vaccines by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Oral Vaccines Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Oral Vaccines by Type (2026-2035)
  12.1.2 Global Oral Vaccines Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Oral Vaccines by Type (2026-2035)
12.2 Global Oral Vaccines Market Forecast by Application (2026-2035)
  12.2.1 Global Oral Vaccines Sales (K MT) Forecast by Application
  12.2.2 Global Oral Vaccines Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oral Vaccines Market Size by Type (M USD)
Table 4. Global Oral Vaccines Market Size by Application
Table 5. Oral Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Oral Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oral Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oral Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oral Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccines as of 2025)
Table 11. Global Market Oral Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oral Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oral Vaccines Sales by Type (K MT)
Table 27. Global Oral Vaccines Market Size by Type (M USD)
Table 28. Global Oral Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Oral Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Oral Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Oral Vaccines Market Share by Type (2020-2025)
Table 32. Global Oral Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Oral Vaccines Sales (K MT) by Application
Table 34. Global Oral Vaccines Market Size by Application
Table 35. Global Oral Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Oral Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Oral Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oral Vaccines Market Share by Application (2020-2025)
Table 39. Global Oral Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Oral Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oral Vaccines Market Size by Region (2020-2025)
Table 44. North America Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oral Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Oral Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oral Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oral Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oral Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Oral Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oral Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oral Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck Oral Vaccines Product Overview
Table 64. Merck Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Oral Vaccines Product Overview
Table 70. GSK Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi Oral Vaccines Product Overview
Table 76. Sanofi Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. Lanzhou Institute Basic Information
Table 81. Lanzhou Institute Oral Vaccines Product Overview
Table 82. Lanzhou Institute Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Lanzhou Institute Business Overview
Table 84. Lanzhou Institute Recent Developments
Table 85. Serum Institute Basic Information
Table 86. Serum Institute Oral Vaccines Product Overview
Table 87. Serum Institute Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Serum Institute Business Overview
Table 89. Serum Institute Recent Developments
Table 90. Valneva Basic Information
Table 91. Valneva Oral Vaccines Product Overview
Table 92. Valneva Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Valneva Business Overview
Table 94. Valneva Recent Developments
Table 95. Shanghai United Cell Basic Information
Table 96. Shanghai United Cell Oral Vaccines Product Overview
Table 97. Shanghai United Cell Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Shanghai United Cell Business Overview
Table 99. Shanghai United Cell Recent Developments
Table 100. Bibcol Basic Information
Table 101. Bibcol Oral Vaccines Product Overview
Table 102. Bibcol Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bibcol Business Overview
Table 104. Bibcol Recent Developments
Table 105. PaxVax Basic Information
Table 106. PaxVax Oral Vaccines Product Overview
Table 107. PaxVax Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. PaxVax Business Overview
Table 109. PaxVax Recent Developments
Table 110. Vabiotech Basic Information
Table 111. Vabiotech Oral Vaccines Product Overview
Table 112. Vabiotech Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Vabiotech Business Overview
Table 114. Vabiotech Recent Developments
Table 115. Tiantan Biological Basic Information
Table 116. Tiantan Biological Oral Vaccines Product Overview
Table 117. Tiantan Biological Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Tiantan Biological Business Overview
Table 119. Tiantan Biological Recent Developments
Table 120. EuBiologics Basic Information
Table 121. EuBiologics Oral Vaccines Product Overview
Table 122. EuBiologics Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. EuBiologics Business Overview
Table 124. EuBiologics Recent Developments
Table 125. Panacea Biotec Ltd Basic Information
Table 126. Panacea Biotec Ltd Oral Vaccines Product Overview
Table 127. Panacea Biotec Ltd Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Panacea Biotec Ltd Business Overview
Table 129. Panacea Biotec Ltd Recent Developments
Table 130. Bio-Med Basic Information
Table 131. Bio-Med Oral Vaccines Product Overview
Table 132. Bio-Med Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Bio-Med Business Overview
Table 134. Bio-Med Recent Developments
Table 135. Halfkin Bio-Pharmaceuticals Basic Information
Table 136. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Overview
Table 137. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Halfkin Bio-Pharmaceuticals Business Overview
Table 139. Halfkin Bio-Pharmaceuticals Recent Developments
Table 140. CNBG Basic Information
Table 141. CNBG Oral Vaccines Product Overview
Table 142. CNBG Oral Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. CNBG Business Overview
Table 144. CNBG Recent Developments
Table 145. Global Oral Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Oral Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Oral Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Oral Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Oral Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Oral Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Oral Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Oral Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Oral Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Oral Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Oral Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Oral Vaccines Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Oral Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oral Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Oral Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Oral Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oral Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oral Vaccines Product Life Cycle
Figure 13. Oral Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Oral Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oral Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oral Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Oral Vaccines
Figure 19. Global Oral Vaccines Market PEST Analysis
Figure 20. Global Oral Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oral Vaccines Market Share by Type
Figure 27. Sales Market Share of Oral Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Oral Vaccines by Type in 2025
Figure 29. Market Share of Oral Vaccines by Type (2020-2025)
Figure 30. Market Share of Oral Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oral Vaccines Market Share by Application
Figure 33. Global Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Oral Vaccines Sales Market Share by Application in 2025
Figure 35. Global Oral Vaccines Market Share by Application (2020-2025)
Figure 36. Global Oral Vaccines Market Share by Application in 2025
Figure 37. Global Oral Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oral Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Oral Vaccines Market Size by Region (2020-2025)
Figure 40. North America Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oral Vaccines Sales Market Share by Country in 2024
Figure 43. North America Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oral Vaccines Market Size by Country in 2024
Figure 45. U.S. Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oral Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oral Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oral Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oral Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oral Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oral Vaccines Market Size by Country in 2024
Figure 55. Germany Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oral Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oral Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oral Vaccines Market Size by Region in 2024
Figure 68. China Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oral Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Oral Vaccines Sales Market Share by Country in 2024
Figure 80. South America Oral Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Oral Vaccines Market Size by Country in 2024
Figure 82. Brazil Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oral Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oral Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oral Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oral Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oral Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oral Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oral Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oral Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oral Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oral Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oral Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oral Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Oral Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Oral Vaccines Market Share Forecast by Application (2026-2035)


More Publications